Inception - 2023
Location - Gurugram, Haryana, India
Industry domain - HealthTech / Consumer Health / Gut Health & Diagnostics
Founders - Mukul Shah and Mansi Sharma
Total Team Strength - 50-55
Total funds raised - Over ₹10.25 crore cumulatively to date, including a ₹4 crore follow-on round in February 2026 .
Investors - Guttify’s investor base includes the family office associated with the Unichem Laboratories family office, Expert Dojo, Agility Ventures, Sunn91 Ventures, government-backed seed programmes, and prominent angel investors including Nitish Mittersain (Nazara Technologies) and Ahana Gautam (Open Secret).
Revenue Generated Since Inception - Business growth metrics: 67% QoQ growth, ~20% monthly user growth and a 40% repeat-user rate.
Current Valuation - Approximately ₹54 crore, based on available reports.
Key Highlights -
Target Fundraise - Having raised over ₹10 crore cumulatively, Guttify is now targeting a ₹20 crore fundraise to strengthen its diagnostic capabilities, expand its product portfolio and deepen its presence across Tier 1 and Tier 2 cities.
Purpose of fundraising - Scaling diagnostic capabilities, technology, product innovation and geographical expansion, particularly across Tier 1 and Tier 2 markets.
Founder Speaks -
Guttify is planning to raise around ₹20 crore to scale its diagnostic capabilities, strengthen technology and accelerate product innovation. The company plans to expand its presence across Tier 1 and Tier 2 cities and broaden its product portfolio across areas such as bloating, digestion and liver health.
- Mukul Shah